Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
暂无分享，去创建一个
H. Sorbye | S. Detlefsen | A. Couvelard | A. Perren | A. Sundlöv | S. Langer | L. Vestermark | G. Hjortland | T. Haslerud | E. Tabaksblat | Siren Morken | Morten Ladekarl | Johanna B Svensson | Jörg Assmus | Anne Couvelard